✦ LIBER ✦

The dopamine D1 receptor agonist SKF 38393 suppresses detrusor hyperreflexia in the monkey with parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)

✍ Scribed by N. Yoshimura; E. Mizuta; S. Kuno; M. Sasa; O. Yoshida

Book ID: 116037563
Publisher: Elsevier Science
Year: 1993
Tongue: English
Weight: 476 KB
Volume: 32
Category: Article
ISSN: 0028-3908
DOI: 10.1016/0028-3908(93)90151-r

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

SKF-38393, a dopamine receptor agonist,

SKF-38393, a dopamine receptor agonist, attenuates 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity

✍ Dhanasekaran Muralikrishnan; Manuchair Ebadi 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 519 KB

The dopamine D2 agonist LY 141865, but n

The dopamine D2 agonist LY 141865, but not the D1 agonist SKF 38393, reverses parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the common marmoset

✍ Nomoto, M.; Jenner, P.; Marsden, C.D. 📂 Article 📅 1985 🏛 Elsevier Science 🌐 English ⚖ 273 KB

Failure of SKF 38393-A to relieve parkin

Failure of SKF 38393-A to relieve parkinsonian symptoms induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the marmoset

✍ S.P. Close; A.S. Marriott; Sharon Pay 📂 Article 📅 1985 🏛 Nature Publishing Group 🌐 English ⚖ 384 KB

Effects of bifemelane on parkinsonism in

Effects of bifemelane on parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the common marmoset

✍ Nomoto, Masahiro; Irifune, Masahiro; Fukuzaki, Kohichiro; Fukuda, Takeo 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 319 KB

The dopamine D1 agonist SKF 81297 and th

The dopamine D1 agonist SKF 81297 and the dopamine D2 agonist LY 171555 act synergistically to stimulate motor behavior of 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-lesioned parkinsonian rhesus monkeys

✍ R. J. Vermeulen; Dr. B. Drukarch; M. C. R. Sahadat; C. Goosen; E. C. Wolters; J. 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 902 KB

## Abstract At present, the pharmacotherapy of Parkinson's disease (PD) consists mainly of L‐dihydroxyphenylalanine (L‐DOPA) and/or dopamine D~2~ receptor agonist. However, in general the clinical efficacy of D~2~ agonists is less than that of L‐DOPA. Therefore, attention is being focussed on the r

Iron accumulation in the substantia nigr

Iron accumulation in the substantia nigra of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced hemiparkinsonian monkeys

✍ Mochizuki, Hideki; Imai, Hisamasa; Endo, Kiyonori; Yokomizo, Kazuko; Murata, Yae 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 467 KB